Differentiation-dependent EBF1 activity determines <i>CD22</i> transcription and leukemia sensitivity to inotuzumab ozogamicin
Carolin S. Escherich(St. Jude Children's Research Hospital), Jun Yang(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), Megan Walker(St. Jude Children's Research Hospital), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Ching‐Hon Pui(St. Jude Children's Research Hospital), Marina Konopleva(The University of Texas MD Anderson Cancer Center), Wenjian Yang(St. Jude Children's Research Hospital), Kelly R. Barnett(St. Jude Children's Research Hospital), Hiroto Inaba(St. Jude Children's Research Hospital), Elisabeth Paietta(Montefiore Medical Center), Xin Huang(St. Jude Children's Research Hospital), Mark R. Litzow(Mayo Clinic in Arizona), Daniel Savic(St. Jude Children's Research Hospital), Zhenhua Li(St. Jude Children's Research Hospital), Yizhen Li(St. Jude Children's Research Hospital), Satoshi Yoshimura(St. Jude Children's Research Hospital), Jiyang Yu(Columbia University Irving Medical Center), Wendy Stock(University of Chicago), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Mignon L. Loh(Seattle Children's Hospital)
Cited by 5
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k